Guidance

Naloxone: a review

The Advisory Council on the Misuse of Drugs has undertaken a review of naloxone's availability.

• From: Advisory Council on the Misuse of Drugs
• Published: 8 May 2012

Documents

Consideration of naloxone (PDF file - 690kb)

PDF, 675 KB, 37 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Letter from the Department of Health to the ACMD

PDF, 48.3 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The Advisory Council on the Misuse of Drugs (ACMD) has undertaken a review of naloxone to decide if it should be more widely available in the UK. The findings of the review are presented in the report.

The attached letter from the Department of Health confirms that work is underway to implement the ACMD’s recommendations.

Published 8 May 2012